AI and in silico models are set to revolutionize biotech investments and transform the entire health innovation ecosystem, join us in our Paris office for this incredible networking event dedicated to this topic.
During the event, the attendees connected with investors and gained insights from seasoned experts and forward-thinking visionaries on how to seamlessly integrate AI, evolve business model, and stay ahead of the competition.
Our esteemed guest speakers, hailing from diverse backgrounds such as institutional VC and startup CEOs, delved into the immense potential of AI in enhancing internal processes, uncovered innovative trends in startups, made predictions for AI in the health ecosystem, and explored the global AI race.
See below how our honored participants value this event!
Speakers
Secretary General and Founding Member at Avicenna Alliance
Thierry is Secretary General of the Avicenna Alliance, a member of the eHealth stakeholder group and a European Commission Member of the EMA stakeholder group. Alongside, Thierry is Industry Director for Healthcare Solutions at Ansys.
Chahra Louafi
Senior Investment Director and Head of the Autonomous Patient Fund at Bpifrance
Senior Investment Director and Head of the Autonomous Patient Fund at Bpifrance
Chahra Louafi is Senior Investment Director and Head of the Autonomous Patient Fund at Bpifrance. Since 2018, she has directed the Autonomous Patient Fund dedicated to digital health, which she set up. Prior, she was responsible for setting up projects and creating companies in a private incubator specializing in biotechnologies. She sits on several boards, counting now up to 10 companies. She was knighted with the French National Order of Merit.
CEO at Ariana Pharma
Mohammed Afshar is CEO of Ariana Pharma, a leading Al driven precision medicine company focused on accelerating clinical drug development and designing advanced therapeutic decision support systems, since its inception in 2003. Alongside his role as a CEO, Mohammad is President of Omicure and part of the Investment Advisory Committee at Seventure.
Business Development Lead at WhiteLab Genomics
Timothé Cynober is Business Development Lead at Whitelab Genomics. Before joining WhiteLab, Timothé held various roles in the field of open innovation, technology transfer and licensing. Namely he was Business Manager for 4 years at Institut Curie and also Open Innovation Manager for 2 years at Novartis France. Timothé has also worked in regulatory affairs consulting at Voisin Consulting Life Sciences.Relive the event
Last events
Event
JPM 2025: Key Learnings from this Year’s J.P. Morgan Healthcare Conference in Neighborhood
Join the Neighborhood team and industry experts for an afterwork event where we’ll debrief and share in-depth insights following the…
Event
2024 Neighborhood Showcase in Neighborhood
After a year of working together on our startups’ roadmaps and development plans, its time to celebrate our 2024 cohort…
Event
Afterwork with the Hub France IA: The Landscape of Digital Twins in Health Tech in Neighborhood
Digital twins are revolutionizing a number of sectors. In health, these virtual models are not only improving R&D, providing rich…
Event
Bioconvergence – The New Investment era in Health in Neighborhood
Neighborhood is proud to Host ENV, a new Pan-European Venture Fund specializing in Healthtech. We are thrilled to host an…
We'd love to get to know you
Join us, we offer you an extraordinary chance to learn, develop and be part of an exciting experience, supported by a knowledgeable team.
Tell us your story